Elon Musk chooses Miami for Neuralink brain-implant research
Elon Musk’s Neuralink has selected Miami as a clinical trial site for its brain-computer interface.
Musk’s Neuralink makes devices that link the human brain to computers, focusing on giving people with quadriplegia or paralysis the ability to control computers and devices with their thoughts. The Miami Project to Cure Paralysis and the Department of Neurological Surgery at the University of Miami will be the second U.S. site to participate in research known as the PRIME Study.
Neuralink is already conducting clinical trials at Barrow Neurological Institute in Phoenix, Ariz. The company announced its first brain implant one year ago and announced earlier this month that a third person had received an implant. Patients who received the implants have been playing video games and online chess by simply thinking about steering left or right.
For the PRIME Study, Neuralink scientists and a multidisciplinary team of neurosurgeons, neuroscientists and biomedical engineers at The Miami Project and the Miller School of Medicine will implant the device in local participants.